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 2 
Abstract 18 
In this study, glycoconjugates of -lactoglobulin ( -lg) and sodium caseinate (SC) 19 
were obtained via Maillard reaction with galactose and lactose, and their ability to 20 
inhibit adhesion of different Escherichia coli strains (CBL2, CBM1 and CBL8) to 21 
mucin was evaluated. The strains tested exhibited different interaction patterns with the 22 
glycoconjugates, suggesting the participation of different carbohydrate-recognition sites 23 
in adhesion. Galactosylation and lactosylation of both -lg and SC significantly 24 
decreased the adhesion values of E. coli CBL2 to mucin. Whereas the adhesion of E. 25 
coli CBM1 was preferably interfered by galactosylated glycoconjugates obtained under 26 
the harshest incubation conditions, the adhesion capacity of E. coli CBL8 was not 27 
affected. Competitive adhesion assays with lectins, which recognize different epitopes, 28 
supported the idea that galactose-reactive adhesins are partly responsible for the 29 
recognition of these glycoconjugates. The analysis of the presence of gene coding for 30 
several virulence factors in the E. coli strains by PCR revealed the absence of K88 gene 31 
in the CBL2 strain assayed. These findings suggest that the formation of Maillard-type 32 
neoglycoproteins under controlled conditions may be a simple and cost-effective 33 
method for producing new food ingredients with the potential ability to block pathogen 34 
adhesins involved in mucosal colonization. 35 
 36 
Keywords: dairy proteins, glycation, adhesion inhibition, Escherichia coli, 37 
functional foods. 38 
39 
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1. Introduction 40 
Many bacterial pathogens use proteins (lectin-like molecules) that bind to 41 
carbohydrates located at the surface of the host tissues to initiate infection (Zopf & 42 
Roth, 1996). Blocking these lectins with suitable carbohydrates that are structurally 43 
similar to the host receptors may be an effective strategy to prevent bacterial adhesion 44 
and infections (Karlsson, 1998; Ofek, Hasty & Sharon, 2003). Nevertheless, production 45 
of synthetic oligosaccharides may be extremely costly and to act effectively, large doses 46 
are normally required (Sharon, 2006). The low effectiveness of oligosaccharides to 47 
inhibit bacterial adhesion may be due to high absorption through the intestinal mucosa, 48 
and/or to low affinity for the bacterial lectins, which makes their use necessary at high 49 
concentrations (Ofek et al., 2003). Consequently, the attachment of many copies of the 50 
saccharide to suitable polymeric carriers, yielding multivalent adhesion sites, has been 51 
proposed as a novel approach to increase the affinity for the bacterial lectins (Sharon, 52 
2006).  53 
In this context, production of neoglycoproteins through the Maillard reaction, the 54 
so-called glycation, under controlled conditions could be an alternative for developing 55 
compounds with anti-adhesive properties. Many studies have demonstrated that 56 
glycation of proteins may be an effective, inexpensive and simple method to produce 57 
glycoconjugates with optimum functionality in real food systems (Oliver, Melton & 58 
Stanley, 2006a). Briefly, the Maillard reaction is initiated by a condensation between 59 
the carbonyl group of a reducing sugar and the free amino group of an amino acid, 60 
peptide or protein ( -amino group of lysine and/or the -amino group of terminal amino 61 
acid), which cyclizes to the N-substituted glycosylamine and is then rearranged to form 62 
the Amadori product. Further reactions, whose nature depends mainly on the amounts 63 
of oxygen, water, temperature and pH of the system, give rise to different compounds 64 
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that include reductones, furfurals, and a variety of other cyclic compounds. Brown 65 
polymers, so-called melanoidins, are the final products of the reaction (Olano & 66 
Martinez-Castro, 1996).  67 
Metabolic studies have shown that Maillard reaction products are poorly digested 68 
and they reach the hind gut where they may be utilized by microorganisms 69 
(Erbersdobler & Faist, 2001; Faist & Erbersdobler, 2001; Finot, 2005). Therefore, it is 70 
plausible that some Maillard reaction glycoconjugates may be available and bind 71 
lectins-like molecules present on the surface of the gut pathogenic bacteria, thereby 72 
inhibiting bacterial adhesion to the intestinal mucosa. Only few studies have evaluated 73 
the interaction of glycated proteins with specific lectins. In this sense, undigested 74 
lactosylated serum albumin from different origin, such as human, bovine and porcine, 75 
showed recognition through the terminal galactose unit of the lactose by liver (Aring, 76 
Schlepperschaefer, Burkart & Kolb, 1989), plant lectins (Ledesma-Osuna, Ramos-77 
Clamont & Vazquez-Moreno, 2008) and Escherichia coli K88 adhesins (Sarabia-Sainz, 78 
Ramos-Clamont, Candia-Plata & Vazquez-Moreno, 2009; Ledesma-Osuna, Ramos-79 
Clamont & Vazquez-Moreno, 2009). Likewise, Hiramoto et al. (2004) showed that a 80 
variety of food protein-derived melanoidins strongly inhibited adhesion of Helicobacter 81 
pylori to urease-gastric mucins and its colonization in mice. 82 
The objectives of this study were to characterize a set of glycoconjugates obtained 83 
by glycation of bovine sodium caseinate or -lactoglobulin with galactose or lactose at 84 
different stages of the Maillard reaction, and to evaluate their ability to inhibit the 85 
adhesion of several intestinal Escherichia coli strains to mucin after simulated 86 
gastrointestinal digestion.  87 
 88 
2. Materials and Methods 89 
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2.1. Preparation and purification of β-Lactoglobulin-galactose/lactose conjugates.  91 
 92 
Carbohydrates, galactose (Gal) or lactose (Lac), and -Lg (mixture of A and B 93 
variants) (Sigma-Aldrich, St. Louis, MO) in a weight ratio of 1:1 or 2:1, respectively, 94 
were dissolved in 0.1 M sodium phosphate buffer, pH 7 (Merck, Darmstadt, Germany), 95 
and lyophilized. The -Lg-Gal powders were kept at 40 and 50 °C for 1 and 2 days, 96 
respectively, whilst the -Lg-Lac powders were kept at 60 °C  for 8 hours and 2 days, 97 
under a vacuum in a desiccator equilibrated at an aw of 0.44, achieved with a saturated 98 
K2CO3 solution (Merck). In addition, control experiments were performed with -Lg 99 
stored at 40, 50 and 60 °C without reducing sugars during the same periods (control 100 
heated -Lg). Incubations were performed in duplicate, and all analytical determinations 101 
were performed at least in duplicate. 102 
After incubation, the products were reconstituted in distilled water to a protein 103 
concentration of 1 mg/mL. To remove free carbohydrate, 2 mL portions were 104 
ultrafiltered through hydrophilic 3 kDa cutoff membranes (Centricon YM-3, Millipore 105 
Corp., Bedford, MA) by centrifugation at 1548g for 2 h. After removal of free Gal or 106 
Lac, samples were reconstituted in distilled water at a concentration of 2 mg/mL for 107 
further analysis (Corzo-Martinez, Moreno, Olano & Villamiel, 2008). 108 
 109 
2.2. Preparation and purification of sodium caseinate-galactose/lactose 110 
conjugates.  111 
 112 
Carbohydrates (Gal or Lac) and sodium caseinate (SC) (Rovita FN 5, Proveedora 113 
Hispano Holandesa, S.A., Barcelona, Spain) in a weight ratio of 0.2:1 were dissolved in 114 
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0.1M sodium phosphate buffer, pH 7.0 (Merck) and lyophilized (Corzo-Martinez, 115 
Moreno, Villamiel & Harte, 2010a). The SC-Gal powders were kept at 60 ºC and 50 ºC 116 
for 4 hours and 3 days, respectively, whilst the SC-Lac powders were kept at 60 ºC for 8 117 
hours and 1 day, under vacuum in a desiccator equilibrated at an aw of 0.67 (Oliver, 118 
Melton & Stanley, 2006b), achieved with a saturated solution of CuCl2 (Sigma–119 
Aldrich,). In addition, control experiments were performed with SC stored at 50 and 60 120 
ºC without reducing sugars during the same periods (control heated SC). Incubations 121 
were performed in duplicate, and all analytical determinations were performed at least 122 
in duplicate. After incubation, free carbohydrates were removed as explained in 123 
subsection 2.1. 124 
 125 
2.3. Evaluation of the progress of the Maillard reaction.  126 
 127 
MALDI-TOF-MS analyses of β-lg:Gal/Lac conjugates were performed using a 128 
Voyager DE-PRO mass spectrometer (Applied Biosystems, Foster City,CA) equipped 129 
with a pulsed nitrogen laser (λ=337 nm, 3 ns pulse width, and 3 Hz frequency) and a 130 
delayed extraction ion source (Corzo-Martinez, Moreno, Olano & Villamiel, 2010b). 131 
Ions generated by the laser desorption were introduced into the flight tube (1.3 m flight 132 
path) with an acceleration voltage of 25 kV, 93% grid voltage, 0.05% ion guide wire 133 
voltage, and a delay time of 350 ns in the linear positive ion mode. Mass spectra were 134 
obtained over the m/z range 10-35 kDa. Myoglobin (horse heart) and carbonic 135 
anhydrase were used for external calibration and sinapinic acid (10 mg/mL in 0.3% 136 
trifluoroacetic acid/ acetonitrile, 70:30, v/v) as the matrix. Samples were mixed with the 137 
matrix at a ratio of approximately 1:15, and finally, 1 μL of this solution was spotted 138 
onto a flat stainless-steel sample plate and dried in air. 139 
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LC/ESI-MS analyses of SC:Gal/Lac conjugates were performed on a Finnigan 140 
Surveyor pump with quaternary gradient system coupled on-line to a Finnigan Surveyor 141 
PDA photodiode array detector and to a Finnigan LCQ Deca ion trap mass spectrometer 142 
using an ESI interface as previously described by Corzo-Martinez et al. (2010a). Thus, 143 
prior to LC/ESI-MS separations, SC:Gal/Lac conjugates were dissolved in 1 mL of 0.1 144 
M Tris/HCl pH 7.0 buffer (Sigma-Aldrich) containing 8 M urea (Riedel-de Haën, 145 
Seelze, Germany) and 20 mM dithiothreitol (DTT, Sigma-Aldrich) to give a final 146 
protein concentration of 10 mg/mL. After standing at 37ºC for 1 hour, samples were 147 
diluted (1/3) with solvent A and filtrated with PVDF membranes (0.45 m, Symta, 148 
Madrid, Spain). LC/ESI-MS experiments were carried out on a Finnigan Surveyor 149 
pump with quaternary gradient system coupled in-line to a Finnigan Surveyor PDA 150 
photodiode array detector and to a Finnigan LCQ Deca ion trap mass spectrometer 151 
using an ESI interface. Sample injections (7 µL) were carried out by a Finnigan 152 
Surveyor autosampler. All instruments were from Thermo Fisher Scientific (San José, 153 
CA, USA). RP-LC separations were carried out with a BioBasic-4 (100 mm x 2.1 mm, 154 
5 µm) column (Thermo Fisher Scientific) at 25 ºC using an adaptation of the method by 155 
Neveu, Mollé, Moreno, Martin & Léonil (2002). Separation was achieved at a flow rate 156 
of 0.2 mL/min and using 0.25% (v/v) of formic acid (analytical grade, Merck, 157 
Darmstadt, Germany) in double-distilled water (Milli-Q water, Millipore, Bedford, 158 
USA) as solvent A and 0.25% (v/v) of formic acid in acetonitrile (LC-MS 159 
Chromasolv® grade, Riedel-de Haën, Seelz, Germany) as solvent B. The elution 160 
program was applied as follows: at the start 20% B; after 2 min the percentage of B was 161 
linearly increased to 40% in 3 min; 40-50% B linear from 5 to 12 min; 50-80% B linear 162 
from 12 to 15min; 80% B isocratic from 15 to 20 min; ramped to original composition 163 
in 1 min; and then equilibrated for 15 min. The PDA detector operated in the 164 
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wavelength range 190–600 nm in order to gather UV-spectral data. The detection 165 
wavelength was set at 280 nm. The mass spectrometer spray voltage was set at 4.5 kV, 166 
heated capillary temperature at 220 °C, nitrogen (99.5% purity) was used as sheath (0.6 167 
L min-1) and auxiliary (6 L min-1) gas, and helium (99.9990% purity) as the collision 168 
gas. Mass spectra were recorded in the negative ion mode. The LC-MS system, data 169 
acquisition and processing were managed by Xcalibur software (1.2 version, Thermo 170 
Fisher Scientific). Spectra of the protein peaks detected were deconvoluted using the 171 
BIOMASS deconvolution tool from BioWorks 3.1 software (Thermo Fisher Scientific). 172 
The fluorescence of the so-called AGEs was measured, as an indicator of the 173 
advanced stages of the Maillard reaction, in a Shimadzu RF-1501 fluorescence 174 
spectrophotometer (Kyoto, Japan) at an excitation wavelength of 340 nm and an 175 
emission wavelength of 415 nm, according to the method of Ponger, Ulrich, Bensath 176 
and Cerami (1984). Samples of native, control heated, and glycated -Lg and SC were 177 
dissolved in 0.1 M sodium phosphate buffer (pH 7.0) to give a final concentration of 1 178 
mg/mL (Corzo-Martinez et al., 2008). 179 
Browning of control heated SC/β-lg, β-lg:Gal/Lac and SC:Gal/Lac conjugates (1 180 
mg/mL in double-distilled water) was measured at room temperature by absorbance at 181 
420 nm in a Beckman DU 70 spectrophotometer (Beckman Instruments Inc., Fullerton, 182 
CA), as an index of the brown polymers formed in more advanced stages of 183 
nonenzymatic browning (Ting & Rouseff, 1986). 184 
 185 
2.4. In vitro gastrointestinal digestion.  186 
 187 
All SC and -lg glycoconjugates, as well as the control heated SC/β-lg samples 188 
were digested in vitro by following the simplified procedure described by Moreno, 189 
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Mackie and Mills (2005). For the gastric digestion step, glycoconjugates (3 mg) were 190 
dissolved in 1 mL of simulated gastric fluid (SGF, 0.15 M NaCl, pH 2.5). The pH was 191 
adjusted to 2.5 with 1 M HCl if necessary. A solution of 0.32% (w:v) porcine pepsin 192 
(EC 3.4.23.1) in SGF (pH 2.5) (Sigma, activity of 3,300 units/mg of protein) was added 193 
at an approximately physiological ratio of enzyme to substrate (1:20, w:w). The 194 
digestion was performed at 37 °C for 2 h. For the intestinal digestion step, the pH was 195 
increased to 7.5 with 40 mM NH4CO3 (Panreac, Barcelona, Spain) dropwise to 196 
inactivate pepsin, and the following was added to adjust the pH to 6.5 and simulate a 197 
duodenal environment: (i) a bile salt mixture containing equimolar quantities (0.125 M) 198 
of sodium taurocholate (Sigma) and glycodeoxycholic acid (Sigma), (ii) 1 M CaCl2 199 
(Panreac), and (iii) 0.25 M Bis-Tris (pH 6.5) (Sigma). Solutions of porcine trypsin (EC 200 
3.4.21.4; 0.05%, w:v, Sigma, type IX-S, activity of 14,300 units/mg of protein) and 201 
bovine -chymotrypsin (EC 3.4.21.1; 0.1%, w:v, Sigma, type I-S, activity of 62 202 
units/mg of protein) in water were prepared and added at approximately physiological 203 
protein:trypsin:chymotrypsin ratios [1:(1/400):(1/100) (w:w:w)]. Simulated intestinal 204 
digestion of samples was carried out at 37 °C for 15 min. After protein hydrolysis, 205 
trypsin and chymotrypsin were inactivated either by heating at 80 ºC for 5 min or by 206 
adding a solution of Bowman-Birk trypsin–chymotrypsin inhibitor from soybean 207 
(Sigma) at a concentration calculated to inhibit twice the amount of trypsin and 208 
chymotrypsin present in the digestion mix. Digestions were performed without any 209 
derivatization of the sulfhydryl groups of cysteine residues in order to remain as close 210 
as possible to physiological conditions. 211 
 212 
2.5. Size-exclusion chromatography analysis.  213 
 214 
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Size-exclusion chromatography (SEC) was carried out under nondenaturing 215 
conditions (0.05 M sodium phosphate buffer, pH 7.0, containing 0.15 M NaCl) using a 216 
Superdex Peptide HR 10/30 column (GE Healthcare Bio-Sciences AB, Uppsala, 217 
Sweden), on an ÄKTA explorer 100 FPLC system. 500 μL of digested glycoconjugates 218 
(1 mg/mL) was applied to the column at room temperature. Elution was achieved in 219 
isocratic mode at 0.5 mL/min for 50 min and detection of eluting proteins was 220 
performed at 280, 214 and 254 nm. The standard proteins used for calibration were 221 
lysozyme (14,400 Da), aprotinin (6,500 Da), insulin B chain (3,500 Da), insulin A chain 222 
(2,500 Da) and tryptophan (204 Da). Void volume was determined with blue dextran 223 
2000. 224 
 225 
2.6. Bacterial cultures.  226 
 227 
Escherichia coli (IATA-CBL2, -CBL8 and -CBM1) strains were isolated from 228 
faeces of human subjects, and identified at species level by conventional 229 
microbiological methods (colony and cellular morphology, and Gram staining) and by 230 
using the API20E system (BioMerieux, Lyon, France) and at strain level by RAPD as 231 
described elsewhere (Sánchez, Nadal, Donat, Ribes-Koninckx, Calabuig & Sanz, 2008). 232 
They were grown in Brain-Heart broth and agar (Scharlau), and incubated at 37 ºC 233 
under aerobic conditions. 234 
 235 
2.7. Adhesion assays to mucin.  236 
 237 
Crude mucin (Type II, Sigma-Aldrich) was diluted in a phosphate buffered solution 238 
(PBS) (pH 7.2) (0.5 mg/mL). An aliquot (0.1 mL) of this solution was loaded into 239 
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polycarbonate 96-well plates (Costar, Cambridge, MA, USA) and incubated at 4 ºC for 240 
24 h. To remove unbound mucin, the wells were washed twice with 0.1 ml PBS. A 241 
fluorescence-based method for the detection of adhesive properties of E. coli strains was 242 
used (Izquierdo, Medina, Ennahar, Marchioni & Sanz, 2008). Bacteria from 20-hour-old 243 
cultures were collected by centrifugation (4,000 x g for 5 minutes at 4 ºC), washed 244 
twice and resuspended in PBS to reach an optical density of 0.5 (A 600). Suspensions of 245 
the different bacterial strains (6.0 x10
7
 - 8.2 x10
8
 CFU/mL) were incubated with 75 246 
µmol/L carboxyfluorescein diacetate (CFDA) (C4916, Sigma-Aldrich), at 37 ºC for 30 247 
minutes. Then, bacteria were washed twice, resuspended with PBS and split in several 248 
sets. Samples were mixed or not with -Lactoglobulin, sodium caseinate and their 249 
glycated derivatives (final concentration of 300 g/mL). Afterwards, 0.1 mL of this cell 250 
labelled suspension was loaded into mucin-covered 96-well plates and incubated at 37 251 
ºC for 1 hour. Afterwards, the media was removed and wells were washed twice with 252 
PBS. Then, 0.2 mL 1% (w/v) sodium dodecyl sulphate (SDS) in 0.1 mol/L NaOH was 253 
added to the wells and incubated at 37 ºC for 30 min. The mixtures were homogenized 254 
by pipetting and the supernatants were transferred to black 96-well plates. The 255 
fluorescence was measured in a multiscan fluorometer (Fluoroskan Ascent, Labsystem, 256 
Oy, Finland) at ex 485 and em 538 nm. Negative controls without bacteria were used 257 
throughout the experiment. 258 
Adhesion was expressed as the percentage of fluorescence recovered after 259 
attachment to mucin relative to the initial fluorescence of the bacterial suspension added 260 
to the wells. 261 
 262 
2.8. Competitive adhesion assays in the presence of lectins.  263 
 264 
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The interactions of bacterial suspensions with the following commercially available 265 
FITC-labeled lectins (Invitrogen, Paisley, UK) were evaluated: soybean agglutinin 266 
(SBA) (L11272), peanut agglutinin (PNA) (L7381), and Helix pomatia agglutinin 267 
(L11271). Bacterial cells (20 h-old cultures) were harvested, washed three times with 268 
PBS (pH 7.2) and then suspended in fresh PBS. Three different sets of samples were 269 
prepared; (1) non treated bacterial cells (control), (2) bacterial cells mixed with specific 270 
agglutinin (final concentration of 20 g/ml) for 15 min, and (3) bacterial cells mixed 271 
with -Lactoglobulin, sodium caseinate or their glycated derivatives (final concentration 272 
of 300 g/mL) for 15 min and then washed twice with PBS and resuspended in PBS 273 
containing the specific agglutinin (20 g/ml) for additional 15 min. After the incubation 274 
period the bacteria were harvested by centrifugation (10,000 x g / 5 min / 4 ºC), and 275 
recovered in 0.5 mL lysis solution (0.1M NaOH, 1% (w/v) SDS). The fluorescence was 276 
measured at ex 485 and em 510 nm. Negative controls without bacteria were also 277 
evaluated.  278 
 279 
2.9. Virulence factor genes detection.  280 
DNA for amplification was released from whole bacteria by heating (100 ºC/6 min) 281 
the bacterial suspensions. Polymerase chain reactions (PCRs) were carried out in a total 282 
volume of 15 µL, consisting of 2.5 µL (60 ng) of DNA template, 7.5 of FastStart Taq 283 
DNA polymerase (Master Mix I, Roche) and 0.5 µL of each primer at appropriate 284 
concentrations and to 15 µL with nuclease free water (Roche) (West, Sprigings, Cassar, 285 
Wakeley, Sawyer & Davies, 2007; Table 1). PCR program consisted of 1 cycle of 286 
denaturation at 94 ºC for 2 min, and by 30 cycles of amplification at 94 ºC for 20s, at 55 287 
ºC for 20s and at 72 ºC for 30s using a LightCycler 480
®
 (Roche) system. Afterwards 288 
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the PCR amplification products were further analyzed in a high-resolution 4.5% agarose 289 
gel and visualized with ethidium bromide staining.  290 
 291 
2.10. Statistical analysis.  292 
 293 
Each of the experiments was conducted in triplicate in two independent assays. One-294 
way analysis of variance (ANOVA) and the Tukey‟s post hoc test were applied. 295 
Statistical significance was established at P<0.05 for all comparisons. SPSS v.15 296 
software (SPSS Inc., Chicago, IL, USA) was used for the statistical analysis. 297 
 298 
3. Results and Discussion 299 
 300 
3.1. Evolution of the Maillard reaction during the formation of glycoconjugates. 301 
 Two different incubation conditions by varying time and temperature were applied 302 
for each type of glycoconjugate (β-lg:Gal/Lac and SC:Gal/Lac) and, then, the progress 303 
of the Maillard reaction was evaluated by different methods (Table 2). Thus, MALDI-304 
TOF and LC/ESI mass spectrometric methods were used to accurately estimate the 305 
number of carbohydrate molecules bound to β-lg and SC, respectively, whilst 306 
fluorescence and absorbance measurements were carried out to assess the formation of 307 
advanced glycation end products (AGEs) and melanoidins (Table 2). Considering that 308 
the choice of MS instrument largely depends on the nature of the sample to be analysed, 309 
among other factors (Yeboah & Yaylayan, 2001), MALDI-TOF-MS analysis allowed a 310 
direct and accurate measurement of the glycation degree of a single protein, such as -311 
lactoglobulin. However, LC/ESI-MS was a more efficient technique to characterize the 312 
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glycated SC and to determine the exact number of carbohydrate molecules bound to 313 
each individual casein fraction previously separated by RP-LC. 314 
Overall, high level of protein glycation was obtained under all assayed incubation 315 
conditions, revealing the efficiency of the Maillard reaction in obtaining multiple 316 
saccharides linked to the same carrier (protein). Thus, β-lg was glycated with up to 13 317 
residues of Lac (after 2 days at 60 ºC) and 19 residues of Gal (after 2 days at 50 ºC), 318 
whereas a maximum of 8 molecules of Lac (after 1 day at 60 ºC) and 14 of Gal (after 4 319 
hours at 60 ºC) were bound to SC. As an example, Figure 1 shows a typical MALDI-320 
MS spectrum of -lactoglobulin glycated with Lac for 2 days at 60 ºC, as well as three 321 
deconvoluted ESI-MS spectra of SC glycated with Lac for 8 hours at 60 ºC. 322 
As it was expected, and despite the harshest conditions used for protein 323 
lactosylation, Gal was more reactive than Lac to form the glycoconjugates. The order of 324 
sugar reactivity in the Maillard reaction is well stated (Chevalier, Chobert, Mollé & 325 
Haertlé, 2001; Nacka, Chobert, Burova, Léonil & Haertlé, 1998; Oliver, Melton & 326 
Stanley, 2006c; Corzo-Martinez et al., 2010a) as monosaccharides are more reactive 327 
than disaccharides and these more reactive than polysaccharides. Thus, it is known that 328 
the smaller the carbonic chain of the sugar is, the more acyclic forms exist and the more 329 
reactive is the sugar with the amino groups of proteins. 330 
On the other hand, a substantial increase in AGEs and melanoidins was observed for 331 
each glycoconjugate as the incubation temperature and time increased, indicating the 332 
progress of the Maillard reaction (Table 2). Thus, within every combination of 333 
carbohydrate and protein, two types of glycoconjugates were prepared at different 334 
stages of the Maillard reaction, one of them consisted primarily of carbohydrates 335 
adducts with a very low content of melanoidins, while those glycoconjugates incubated 336 
 15 
under more severe conditions were also susceptible to contain considerable amounts of 337 
AGEs and melanoidins. 338 
  339 
3.2. Size-exclusion chromatographic (SEC) analysis of fragments derived from 340 
the gastrointestinal digestion of the glycoconjugates. 341 
 342 
 To simulate the physiological conditions, glycoconjugates were subjected to an in 343 
vitro gastrointestinal digestion model consisting of a first stage of gastric digestion with 344 
pepsin for 2 hours at 37 ºC and a second stage of duodenal digestion with 345 
trypsin/chymotrypsin for 15 minutes at 37 ºC.  346 
Due to the complexity of the Maillard reaction, protein aggregation can take place 347 
through different mechanisms. Nonetheless, one of the most common is that the 348 
corresponding Amadori compound (formed during the initial stages of the Maillard 349 
reaction and derived from the re-arrangement of the Schiff base) is readily degraded to 350 
reactive (di)carbonyl intermediates, which may act as precursors of aggregate 351 
compounds formed during the advanced and final stages of this reaction (Ledl & 352 
Schleicher, 1990; Yaylayan & Huyghues-Despointes, 1994). Since the Maillard reaction 353 
progressed to advanced stages upon the incubation time and temperature, we have 354 
considered the existence of peptide aggregates as a potential factor that could influence 355 
the anti-adhesive properties of the produced compounds. Thus, to assess digestibility 356 
and size of generated peptides, hydrolysed glycoconjugates were analysed by SEC at 357 
pH 7.0 in the presence of 0.15 M NaCl. SC glycoconjugates were more efficiently 358 
digested than complexes derived from -lg, regardless of the employed glycation 359 
conditions (Figure 2). This result can be attributed to the fact that caseins have a 360 
flexible and linear conformation rather than a rigid and compact structure 361 
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(Kaminogawa, 2000), facilitating their enzymatic digestion. In contrast, -lactoglobulin 362 
presents a high structural stability at acid pH, having its peptic cleavage sites 363 
(hydrophobic or aromatic amino acid side chains) buried inside its characteristic -364 
barrel structure, forming a strong hydrophobic core and preventing hydrolysis (Reddy, 365 
Kella & Kinsella, 1988; Dalgalarrondo, Dufour, Chobert, Bertrand-Harb & Haertlé, 366 
1995).  367 
Concerning aggregation levels upon the incubation period, the most notable 368 
differences were found following SC glycation with Gal as it was observed a substantial 369 
increase in the area of the less retained peaks after incubation under more severe 370 
conditions, i.e. 3 days at 50 ºC (Figure 2A). This behaviour could also be observed for 371 
-lg glycoconjugates (Figures 2C and 2D). The formation of protein aggregates with 372 
increasing incubation time and/or temperature may be related to important structural 373 
changes derived from extensive cross-linking reactions that occur during the advanced 374 
stages of the Maillard reactions. 375 
 376 
3.3. Effects of glycated proteins on inhibition of bacterial adhesion.  377 
 378 
The effects of -Lg, SC and their glycoconjugates, after in vitro gastrointestinal 379 
digestion, on the adhesion percentages of different E. coli strains are shown in Table 3. 380 
E. coli strains tested exhibited similar (P>0.05) adhesion values to mucin-covered wells. 381 
Only native (unglycated) -Lg and SC caused a significant increase (P<0.05) of the 382 
adhesion percentages of E. coli CBL8 to mucin when compared with controls; however, 383 
this effect was not observed for E. coli CBL2 and CBM1 strains. Native -Lg or SC 384 
subjected to the harshest experimental conditions applied during the glycation process 385 
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did not affect differently the adhesion percentages of the E. coli strains in comparison to 386 
the glycated counterparts (data not shown). 387 
The glycoconjugates of both -Lg and SC influenced bacterial adhesion percentages 388 
as a function of the E. coli strain considered. The galactose- or lactose-derived 389 
conjugates of -Lg decreased the adhesion of E. coli CBL2, and there were not 390 
statistical differences depending on the number of bound galactose molecules for each 391 
derivate. Nevertheless, lactose-derived -lg and SC glycoconjugates incubated under 392 
the most severe conditions also decreased, although to a lesser extent, the adhesion of E. 393 
coli CBL2 (Table 3). The adhesion of E. coli CBM1 was significantly (P<0.05) 394 
decreased by lactose- and galactose-derived glycoconjugates of -lg, as well as by 395 
galactose-derived glycoconjugates of SC, obtained with the harshest glycation 396 
conditions applied (2 days at 60 ºC and 50 ºC for lactosylated and galactosylated β-lg 397 
conjugates, respectively, and 3 days at 50 ºC for galactosylated SC conjugates). The 398 
products generated during the Maillard reaction did not interfere with the effect of these 399 
glycoconjugates on E. coli CBL8 adhesion (Table 3).  400 
Adhesion of pathogenic bacteria to the intestine has been considered as a first step 401 
of invasion and infections. However, scarce studies have been done to evaluate the 402 
potential properties of dietary carbohydrates or derivatives to inhibit adhesion of 403 
potentially pathogenic intestinal bacteria (Shoaf, Mulvey, Armstrong & Hutkins, 2006; 404 
Laparra & Sanz, 2009; Sarabia-Sainz et al., 2009.) In this study, adhesion of the E. coli 405 
strains tested are in the same range as those previously reported for E. coli CBL2 (5.1%) 406 
by using a classical mucin adhesion assay and different configurations of a human 407 
intestinal epithelial cell line (Caco-2) culture (Laparra & Sanz, 2009). These authors 408 
demonstrated significant differences (P<0.05) in the adhesion percentages of two E. coli 409 
strains (CBL2 and CBD10) isolated from faeces, although, both exhibited a preferential 410 
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adhesion to intestinal cells. In this study, the inhibition of E. coli adhesion by -Lg or 411 
SC glycoconjugates was strain-dependent, suggesting the involvement of different 412 
carbohydrate-recognition sites in the interactions between the glycoconjugates and the 413 
cell surface molecules of the bacteria. 414 
Factors involved in pathogen adhesion to the intestinal mucosa include lectin-like 415 
structures that bind carbohydrates (Ofek, Hasty, Abraham & Sharon, 2000; Shoaf et al., 416 
2006) or glycoconjugate receptor molecules (Ofek et al., 2000). The binding specificity 417 
of E. coli strains to different defined lectins is shown in Figure 3A. Soybean agglutinin 418 
(SBA) binds specifically to - and -N-acetilgalactosamine (galNAc) and 419 
galactopiranosil residues, Helix pomatia agglutinin (HPA) exhibits affinity for -N-420 
acetilgalactosamine residues, and Peanut agglutinin (PNA) for -galactose(1-3)galNAc 421 
residues. The different E. coli strains tested exhibit similar PNA recognition capacity. 422 
However, there was a significant difference on the recognition of SBA following the 423 
order: CBL2 > CBM1 > CBL8. In addition, E. coli CBM1 exhibited the lowest binding 424 
capacity to HPA. These results evidenced the abundance of sites recognized by SBA in 425 
the E. coli strains tested; therefore, SBA was used for competition assays with -Lg:Gal 426 
(1 day/40 ºC) or SC:Gal (4 h/60 ºC) (Figure 3B). These glycoconjugates were chosen 427 
because of the higher efficiency in the glycation process, diminishing the appearance of 428 
advanced products of the Maillard reaction (Table 2). The incubation of both 429 
glycoconjugates with the bacterial suspensions caused a significant (P<0.05) decrease in 430 
SBA binding to E. coli CBL2 and CBM1, but did not affect SBA binding to E. coli 431 
CBL8. The sharp reduction in the SBA binding to E. coli CBL2 is concordant with the 432 
marked (P<0.05) reduction in the adhesion percentages to mucin calculated for this 433 
strain in the presence of the glycoconjugates (Table 3). In contrast, SBA binding 434 
capacity to E. coli CBL8 was not affected by the glycoconjugates. This behaviour is in 435 
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agreement with the unaltered adhesion percentages of E. coli CBL8 to mucin in 436 
presence of both compounds tested. Interestingly, both glycoconjugates caused a 437 
significant (P<0.05) decrease in the SBA binding capacity of E. coli CBM1, but it was 438 
not accompanied of a significant reduction in its adhesion values (Table 3). These 439 
results indicate that molecules of a different nature are involved in the adhesion of E. 440 
coli CBM1 to mucin. Taken together, these results suggest that galactose-reactive lectin 441 
like adhesins may be responsible, at least in part, for the recognition of the 442 
glycoconjugates tested in the adhesion assays. 443 
It has been reported that several oligosaccharides (firstly, galactooligosaccharides 444 
and, secondly, lactulose, inulin and inulin-like) inhibit enteric pathogen adhesion 445 
interfering with their recognition binding sites that coat the surface of the 446 
gastrointestinal epithelial cells (Shoaf et al., 2006; Kunz & Rudloff, 2008). In this study, 447 
the results strongly suggest that both -Lg:Gal/Lac and SC:Gal/Lac glycoconjugates are 448 
recognized by E. coli CBL2 clearly interfering with its adhesion to mucin. To the best 449 
of our knowledge, these results represent the first evidence of the inhibitory effect of 450 
galactosylated proteins, obtained via Maillard reaction, on in vitro E. coli adhesion after 451 
simulated gastrointestinal digestion. However, it has been previously reported that 452 
undigested neoglycoconjugates obtained by non-enzymatic lactosylation of serum 453 
albumin from different species can reduce E. coli adhesion (Ledesma-Osuna et al., 454 
2009; Sarabia-Sainz et al., 2009), and liver and plant lectins adhesion (Aring et al., 455 
1989; Ledesma-Osuna et al., 2008).  456 
The different effects caused by the glycoconjugates on adhesion of the E. coli strains 457 
tested evidence the heterogeneity of molecules involved in such interactions in this 458 
bacterial group. Some of the molecular pathogenic mechanisms of E. coli have been 459 
characterized, revealing the involvement of complex pathogen-host interactions through 460 
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a heterogeneous group of protein(aceous) surface molecules (Fleckenstein, Hardwidge, 461 
Munson, Rasko, Sommerfelt & Steinsland, 2010). The involvement of enterotoxigenic 462 
invasion protein A (Tia) binding to acidic carbohydrates such as heparan sulfate 463 
proteoglycans (Fleckenstein, Holland & Hasty, 2002), among others, has been reported. 464 
Proteoglycans composed of disaccharide units, hexosamine (D-glucosamine or D-465 
galactosamine) and uronic acid (D-glucuronic acid or L-iduronic acid) or galactose 466 
(keratin sulfate) are also major components in the extracellular matrix, which might 467 
constitute binding sites for bacterial adhesion (Sasisekharan & Myette, 2003; Laparra, 468 
Lopez-Rubio, Lagaron & Sanz, 2010). Mucins are a family of high molecular weight 469 
heavily glycosylated proteins (glycoconjugates), produced by epithelial tissues that are 470 
also potential targets for the E. coli Tia-mediated adhesion to mucin. 471 
The gene carriage of virulence factors such as lectin like adhesins (fimbriae or pili) 472 
can also have an important impact on the ability of E. coli strains to colonize the small 473 
intestine (Fleckenstein et al., 2010). In this study, the presence of different virulence 474 
factor genes in the E. coli strains was tested by PCR (Table 1) using a normalized DNA 475 
concentration (60 ng). The resulting amplification products were resolved in high 476 
resolution agarose (4.5%) gel (Figure 4). The results revealed that CBL8 and CBM1, 477 
but not CBL2, exhibited amplification products for K88, although, all three strains 478 
presented amplification products for K99, F41 and heat labile toxin (Hlt). 479 
The gene carriage of F41, but not K88, may explain, at least in part, the differences 480 
observed in the inhibitory effect of -Lg:Gal (1 day/40 ºC) or SC:Gal (4 h/60 ºC) in E. 481 
coli CBL2 and CBM1 adhesion. The observation that neoglycoconjugates did not affect 482 
E. coli CBL8 adhesion could be attributed to the absence of their interaction with the 483 
fimbrial adhesin K88, which was not detected in E. coli CBL2 (Figure 4). Specific 484 
associations of the virulence factors, K88/Hlt and K99/F41, have been reported in 485 
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porcine E. coli ETEC strains (West et al., 2007), which frequently express fimbrial 486 
adhesins similar to human E. coli ETEC strains (Fleckenstein et al., 2010). Research 487 
efforts were made identifying the participation of fimbriae K88 (Sarabia-Sainz et al., 488 
2009; Koh, George, Brözel, Moxley, Francis & Kaushik, 2008) and K99/F41 in the 489 
porcine E. coli ETEC adhesion to human intestinal embryonic (INT-407) (Koh et al., 490 
2008) or epithelial (Caco-2) cells (Roubos-van den Hil, Nout, Beumer, van der Meulen 491 
& Zwietering, 2009).  492 
 493 
4. Conclusion 494 
Our results show that gastrointestinal digested bovine -lg-Gal/Lac and SC-Gal/Lac 495 
glycoconjugates may contribute to inhibiting E. coli adhesion to mucin. These 496 
glycoconjugates showed a strain-dependent effect, suggesting the involvement of 497 
different carbohydrate-recognition sites. In this sense, competitive adhesion assays for 498 
lectin-like adhesion sites in the E. coli strains suggested that galactose-reactive sites 499 
may be partly responsible for the recognition of these glycoconjugates. Furthermore, the 500 
extent of the Maillard reaction could also have an effect of the anti-adhesive activity of 501 
glycoconjugates. Although in vivo studies should be conducted, the present findings 502 
indicate that production of Maillard-type glycoconjugates, with a high number of 503 
attached carbohydrates, is a possible strategy to block pathogen adhesins involved in 504 
mucosal colonization and infections. 505 
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Figure Captions. 648 
 649 
Figure 1. (A) MALDI-TOF-MS spectrum of -Lg glycated with Lac at 60 ºC for 2 650 
days; and deconvoluted ESI-MS spectra of glycated forms of (B) -, (C) s1-, and (D) 651 
-casein for SC glycated with Lac at 60 ºC for 8 hours. 652 
 653 
Figure 2. Size-exclusion chromatography profile of the in vitro gastrointestinal digested 654 
glycoconjugates derived from SC (A and B) and -Lg (C and D). Elution positions of 655 
standard proteins are indicated by arrows: a, lysozyme (Mr 14,400); b, aprotinin (Mr 656 
6,500); c, insulin B chain (Mr 3,500); d, insulin A chain (Mr 2,500); e, tryptophan (Mr 657 
204). 658 
 659 
Figure 3. Lectin (soybean agglutinin, SBA; peanut agglutinin, PNA, and Helix pomatia 660 
agglutinin, HPA) binding to different E. coli strains (A) and (B) effect of the different 661 
glycoconjugates, after in vitro gastrointestinal digestion, on soybean agglutinin binding 662 
by different E. coli strains. * Indicates statistically significant differences for the same 663 
strain. 664 
 665 
Figure 4. Virulence factor genes in different Escherichia coli strains; fimbrial antigens 666 
(K99, F41, K88) and heat labile toxin (Hlt). 667 
 1 
Table 1. Oligonucleotide primers used for virulence factor genes amplification. 
 
 
 
 
 
 
 
 
 
 
 
 
a 
Fimbrial antigens; 
b
 Hlt, heat labile toxin. 
Target Oligonucleotide sequence 
(5’–3’) 
Working 
concentration 
(µM) 
Accession 
number 
Product 
size 
(bp) 
K88
a
 ggttcagtgaaagtcaatgcatct 20 AJ616236 70 
 ccccgtccgcagaagtaac 20   
K99
a
 gctattagtggtcatggcactgtag 35 M35282 80 
 tttgttttcgctaggcagtcatta 35   
F41
a
 ctgctgattggacggaaggt 30 X14354 88 
 ccagtcttccatagccatttaacag 30   
Hlt
b
 ccggcagaggatggttacag 20 K01995 73 
 gaatccagggttcttctctccaa 20   
Table(s)
 2 
Table 2. AGE fluorescence, absorbance at 420 nm and number of galactose (Gal) or lactose (Lac) molecules bound to glycated -lactoglobulin 
(β-Lg) and sodium caseinate (SC) estimated by mass spectrometry. 
 
Glycoconjugates 
Incubation 
conditions 
Number of attached carbohydrate 
adducts 
AGEs 
(Fluorescence Intensity) 
Melanoidins  
(Absorbance Units) 
β-Lg:Gal 
40 ºC, 1 day 14
a 
46.0 ±2.6 c 0.022 ±0.002 
50 ºC, 2 days 19
a 
90.5 ±0.3 0.229 ±0.002 
β-Lg:Lac 
60 ºC, 8 hours 10
a 
12.6 ±0.6 0.004 ±0.000 
60 ºC, 2 days 13
a 
74.0 ±0.3 0.139 ±0.001 
SC:Gal 
 60 ºC, 4 hours  
14
b
 
17.0 ±0.5 
0.010 ±0.001 
 50 ºC, 3 days  Not detected 
59.5 ±0.8 0.101 ±0.014 
SC:Lac 
60 ºC, 8 hours 
6
b 
16.4 ±1.1 0.006 ±0.001 
60 ºC, 1 day 
8
b 
46.6 ±1.1 0.059 ±0.003 
a
 Average number estimated by MALDI-TOF-MS. 
b
 Estimated by LC/ESI-MS according to Corzo-Martinez et al. (2010a). 
c
 Data are average of two independent experiments ± standard deviation of the mean. 
 3 
Table 3. Effect of the different glycoconjugates (Gal, galactose and Lac, lactose) of -lactoglobuline or sodium caseinate, after in vitro 
gastrointestinal digestion, on the adhesion percentages of E. coli strains CBL2, CBL8 and CBM1 to mucin. 
a-c 
Different case letters within a row 
indicate statistically significant (P<0.05) differences. 
 
 
Bacteria 
 -lactoglobulin 
Mucin Native Gal, 1d/40 ºC Gal, 2d/50 ºC Lac, 8h/60 ºC Lac, 2d/60 ºC 
       
CBL2 5.56 ± 0.31
 a
 5.55 ± 0.41
 a
 3.49 ± 0.36
 b
 3.62 ± 0.59
 b
 3.67 ± 0.28
 b
 4.31 ± 0.31
 c
 
CBL8 5.30 ± 0.41 
a,b,c
 6.56 ± 0.38 
d
 5.19 ± 0.08 
a
 5.62 ± 0.48 
c,d
 5.23 ± 0.23 
a,b
 6.07 ± 0.64 
b,c,d
 
CBM1 5.09 ± 0.80
 a,b
 4.78 ± 0.51
 a,b
 4.44 ± 0.58
 b,c
 3.94 ± 0.19
 c
 5.20 ± 0.36
 a
 4.00 ± 0.18
 c
 
       
       
  Sodium caseinate 
 Mucin Native Gal, 4h/60 ºC Gal, 3d/50 ºC Lac, 8h/60 ºC Lac, 1d/60 ºC 
       
CBL2 5.56 ± 0.31
 a
 6.05 ± 0.41
 a
 3.48 ± 0.48
 b
 4.27 ± 0.44
 a,b
 3.63 ± 0.34
 b
 4.44 ± 0.62
 c
 
CBL8 5.30 ± 0.41 
a,b
 5.91 ± 0.75 
a,b
 6.11 ± 1.07 
b
 4.95 ± 0.07 
a
 5.88 ± 1.26 
a,b
 5.45 ± 0.35 
a,b
 
CBM1 5.09 ± 0.80
 a,b
 5.62 ± 0.48
 b
 5.43 ± 0.57
 a,b
 4.21 ± 0.39
 c
 5.73 ± 0.29
 b
 5.05 ± 0.63
 a,b
 
       
Figure 1. Laparra et al. 
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Figure 2. Laparra et al. 
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Figure 3. Laparra et al. 
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Figure 4. Laparra et al. 
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